MedPath

NASAL ALLERGY AND CONGESTION RELIEF

NASAL ALLERGY AND CONGESTION RELIEF

Approved
DIN Number

02451905

Drug Class

Human

Market Date

N/A

Company
HC

Apotex Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02451905
AIG Number0121732002
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
R01AD09 MOMETASONE
Product Specifications
Dosage FormSpray, Metered Dose
Route of AdministrationNasal
AHFS Classification52:08.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

MOMETASONE FUROATEActive
Strength: 50 MCG / SPRAY
Monograph: MOMETASONE FUROATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.